Status
Conditions
Treatments
About
The aim of the study is to assess the real-world effectiveness of managing participants within the first year post-activation (between 3 and 12 months) using Cochlear's Remote Care (Remote Check and Remote Assist), as compared with standard in-clinic management. The study captures also the time and costs associated with both models of care to quantify the potential costs savings and efficiency gains possible with delivering Cochlear Implant (CI) aftercare remotely.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Patient has a MAP incompatible with Master Volume, Bass and Treble (MVBT) programming:
Patient has on-going fluctuations in MAP Threshold levels (Ts) and Comfort levels (Cs) and/or impedances
Patient requires frequent individual channel measurements and/or measurements without the use of live-stimulation
Score below 3 on the screening subset of questions from the Mobile Device Proficiency Questionnaire (MDPQ)
Abnormal cochlea anatomy and/or facial nerve stimulation that requires complex or more frequent programming, as determined by the Investigator
Additional disabilities that would prevent participation in evaluations, including significant visual impairment and/or dexterity issues
Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator
Investigator site personnel directly affiliated with this study and/or their immediate families; immediate family is defined as a spouse, parent, child, or sibling
Cochlear employees or employees of Contract Research Organisations or contractors engaged by Cochlear for the purposes of this investigation
Current participation, or participation in another interventional clinical study/trial in the past 30 days, involving an investigational drug or device (unless the other investigation was/is a Cochlear sponsored investigation and determined by the investigator or Sponsor to not impact this investigation).
Primary purpose
Allocation
Interventional model
Masking
148 participants in 2 patient groups
Loading...
Central trial contact
PRS Specialist, Clinical Affairs
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal